Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Adams J: Proteasome inhibition in cancer: development of PS-341. Semin Oncol 2001, 28:613–619.
2. Elliott PJ, Ross JS: The proteasome: a new target for novel drug therapies. Am J Clin Pathol 2001, 116:637–646.
3. Pervan M, Pajonk F, Sun JR, et al.: Molecular pathways that modify tumor radiation response. Am J Clin Oncol 2001, 24:481–485.
4. An WG, Hwang SG, Trepel JB, Blagosklonny MV: Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/ CIP1, and induction of apoptosis are independent markers of proteasome inhibition. Leukemia 2000, 14:1276–1283.
5. Sunwoo JB, Chen Z, Dong G, et al.: Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin Cancer Res 2001, 7:1419–1428.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献